Publications – Center for Communicable Disease Dynamics

Tracking COVID-19 Infections Using Survey Data on Rapid At-Home Tests.

Author(s): Santillana M, Uslu AA, Urmi T, Quintana-Mathe A, Druckman JN, Ognyanova K, Baum M, Perlis RH, Lazer DJournal: JAMA Netw OpenPMID: 39348120 September 2024

Importance Identifying and tracking new infections during an emerging pandemic is crucial to design and deploy interventions to protect populations and…

Conspiratorial thinking in a 50-state survey of American adults

Author(s): Perlis RH, Uslu A, Barroilhet SA, Vohringer PA, Santillana M, Baum MA, Druckman JN, Ognyanova K, Lazer DJournal: medRxiv September 2024

While the NIMH Research Domain Criteria framework stresses understanding how neuropsychiatric phenotypes vary across populations, little is known outside of…

Prevalence and correlates of irritability among U.S. adults.

Author(s): Perlis RH, Uslu A, Schulman J, Himelfarb A, Gunning FM, Solomonov N, Santillana M, Baum MA, Druckman JN, Ognyanova K, Lazer DJournal: NeuropsychopharmacologyPMID: 39181998 August 2024

This study aimed to characterize the prevalence of irritability among U.S. adults, and the extent to which it co-occurs with…

Trust in Physicians and Hospitals During the COVID-19 Pandemic in a 50-State Survey of US Adults.

Author(s): Perlis RH, Ognyanova K, Uslu A, Lunz Trujillo K, Santillana M, Druckman JN, Baum MA, Lazer DJournal: JAMA Netw OpenPMID: 39083270 July 2024

Trust in physicians and hospitals has been associated with achieving public health goals, but the increasing politicization of public health…

Cognitive Symptoms of Post-COVID-19 Condition and Daily Functioning.

Author(s): Jaywant A, Gunning FM, Oberlin LE, Santillana M, Ognyanova K, Druckman JN, Baum MA, Lazer D, Perlis RHJournal: JAMA Netw OpenPMID: 38353947 February 2024

The frequent occurrence of cognitive symptoms in post-COVID-19 condition has been described, but the nature of these symptoms and their…

Community Mobility and Depressive Symptoms During the COVID-19 Pandemic in the United States.

Author(s): Perlis RH, Lunz Trujillo K, Safarpour A, Quintana A, Simonson MD, Perlis J, Santillana M, Ognyanova K, Baum MA, Druckman JN, Lazer DJournal: JAMA Netw OpenPMID: 37755830 September 2023

Marked elevation in levels of depressive symptoms compared with historical norms have been described during the COVID-19 pandemic, and understanding…

Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19.

Author(s): Perlis RH, Lunz Trujillo K, Green J, Safarpour A, Druckman JN, Santillana M, Ognyanova K, Lazer DJournal: JAMA Health ForumPMID: 37773507 September 2023

The COVID-19 pandemic has been notable for the widespread dissemination of misinformation regarding the virus and appropriate treatment.

Comparison of post-COVID depression and major depressive disorder.

Author(s): Perlis RH, Santillana M, Ognyanova K, Green J, Druckman JN, Lazer D, Baum MAJournal: medRxivPMID: 33821286 April 2021

During the COVID-19 pandemic rates of depressive symptoms are markedly elevated, particularly among survivors of infection. Understanding whether such symptoms…